Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway
Lina He, Yingyi Liu, Kun Wang, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 575, pp. 1-7
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Targeting ferroptosis in acute kidney injury
Lihua Ni, Yuan Cheng, Xiaoyan Wu
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 127
High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2-Mediated Autophagy Dysfunction and Ferroptosis
Wei Yu, Weidong Liu, De Xie, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 83
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 54
The mechanisms of ferroptosis and its role in atherosclerosis
Xi Xu, Xiaodan Xu, Mengqing Ma, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116112-116112
Open Access | Times Cited: 41
Gualou-Xiebai herb pair ameliorate atherosclerosis in HFD-induced ApoE−/− mice and inhibit the ox-LDL-induced injury of HUVECs by regulating the Nrf2-mediated ferroptosis
Li Zhu, Youli Bao, Zijian Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117892-117892
Closed Access | Times Cited: 16
Regulated Necrosis in Atherosclerosis
Pauline Puylaert, Michelle Zurek, Katey J. Rayner, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 11, pp. 1283-1306
Open Access | Times Cited: 60
Icariin alleviates ferroptosis‐related atherosclerosis by promoting autophagy in xo‐LDL‐induced vascular endothelial cell injury and atherosclerotic mice
Xindong Wang, Meng Zhang, Chenhan Mao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 3951-3963
Closed Access | Times Cited: 24
Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases
Hang Han, Guojiang Zhang, Xiao Zhang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2961-2986
Closed Access | Times Cited: 14
Berberine as a novel ACSL4 inhibitor to suppress endothelial ferroptosis and atherosclerosis
Yang Hong, Jing Feng, Zijia Dou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117081-117081
Open Access | Times Cited: 12
Puerarin Attenuates Iron Overload‐Induced Ferroptosis in Retina through a Nrf2‐Mediated Mechanism
Qiongtao Song, Wenyuan Jian, Yuanyuan Zhang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 11
Targeting ferroptosis in ischemia/reperfusion renal injury
Komal Thapa, Thakur Gurjeet Singh, Amarjot Kaur
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 11, pp. 1331-1341
Closed Access | Times Cited: 34
Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway
Zhuang‐Hua Liu, Zhaopeng Zhou, Pu Ai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
The role of ferroptosis in metabolic diseases
Ling Xie, Bin Fang, Chun Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119480-119480
Open Access | Times Cited: 18
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
Hu Li, Pengbo Hu, Yajun Zou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases
Ye Yang, Mingyan Shao, Wenkun Cheng, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 17
Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis
Chunkun Yang, MU Yan-guang, Shuanghong Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Herbal medicines provide regulation against iron overload in cardiovascular diseases: Informing future applications
Jia Liu, Liangyan Deng, Liping Qu, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117941-117941
Closed Access | Times Cited: 8
Ferroptosis in age-related vascular diseases: Molecular mechanisms and innovative therapeutic strategies
Yue Dai, Xiuxian Wei, Tao Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116356-116356
Open Access | Times Cited: 6
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual‐like protein 1 and acyl‐coenzyme A synthetase long‐chain family member 4 signaling pathway
Shuai Zhu, Zhiqiang Kang, Fengjiao Zhang
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 8, pp. 1003-1016
Open Access | Times Cited: 6
Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway
Siming Xue, Huan Chen, Jingmei Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118604-118604
Closed Access | Times Cited: 6
Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma
Wei Mao, Jian Ding, Yu Li, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 27
San-Huang-Yi-Shen capsule ameliorates diabetic nephropathy in mice through inhibiting ferroptosis
Shuquan Lv, Huajun Li, Tianyu Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115086-115086
Open Access | Times Cited: 15
The complex interplay between ferroptosis and atherosclerosis
Mao Zhang, Jianping Li, Wei Hu
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117183-117183
Open Access | Times Cited: 4
Ferroptosis, pathogenesis and therapy in AS co-depression disease
Yulong Zhao, Peng Ren, Qiang Luo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Research Progress on the Prevention and Treatment of Atherosclerosis Based on the Mechanism of Ferroptosis
振兴 史
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 958-966
Closed Access
Page 1 - Next Page

Scroll to top